These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
455 related articles for article (PubMed ID: 26813745)
1. Barrett's Esophagus: A Comprehensive and Contemporary Review for Pathologists. Naini BV; Souza RF; Odze RD Am J Surg Pathol; 2016 May; 40(5):e45-66. PubMed ID: 26813745 [TBL] [Abstract][Full Text] [Related]
2. Cdx2 expression and its promoter methylation during metaplasia-dysplasia-carcinoma sequence in Barrett's esophagus. Makita K; Kitazawa R; Semba S; Fujiishi K; Nakagawa M; Haraguchi R; Kitazawa S World J Gastroenterol; 2013 Jan; 19(4):536-41. PubMed ID: 23382633 [TBL] [Abstract][Full Text] [Related]
3. Endoscopic Raman spectroscopy enables objective diagnosis of dysplasia in Barrett's esophagus. Almond LM; Hutchings J; Lloyd G; Barr H; Shepherd N; Day J; Stevens O; Sanders S; Wadley M; Stone N; Kendall C Gastrointest Endosc; 2014 Jan; 79(1):37-45. PubMed ID: 23886354 [TBL] [Abstract][Full Text] [Related]
4. Increasing diagnostic accuracy to grade dysplasia in Barrett's esophagus using an immunohistochemical panel for CDX2, p120ctn, c-Myc and Jagged1. Karamchandani DM; Lehman HL; Ohanessian SE; Massé J; Welsh PA; Odze RD; Goldblum JR; Berg AS; Stairs DB Diagn Pathol; 2016 Feb; 11():23. PubMed ID: 26926447 [TBL] [Abstract][Full Text] [Related]
5. What the gastroenterologist needs to know about the histology of Barrett's esophagus. Odze RD Curr Opin Gastroenterol; 2011 Jul; 27(4):389-96. PubMed ID: 21543978 [TBL] [Abstract][Full Text] [Related]
6. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association. Wani S; Rubenstein JH; Vieth M; Bergman J Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561 [TBL] [Abstract][Full Text] [Related]
7. Esophageal adenocarcinoma arising in cervical inlet patch with synchronous Barrett's esophagus-related dysplasia. Tanaka M; Ushiku T; Ikemura M; Shibahara J; Seto Y; Fukayama M Pathol Int; 2014 Aug; 64(8):397-401. PubMed ID: 25143128 [TBL] [Abstract][Full Text] [Related]
8. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus. Whitson MJ; Falk GW Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196 [TBL] [Abstract][Full Text] [Related]
9. The diagnosis and management of Barrett's esophagus. DeMeester SR; DeMeester TR Adv Surg; 1999; 33():29-68. PubMed ID: 10572561 [TBL] [Abstract][Full Text] [Related]
10. Esophageal polypoid dysplasia of gastric foveolar phenotype with focal intramucosal carcinoma associated with Barrett's esophagus. Asthana N; Mandich D; Ligato S Am J Surg Pathol; 2008 Oct; 32(10):1581-5. PubMed ID: 18724240 [TBL] [Abstract][Full Text] [Related]
11. Trefoil Factor Expression in a Human Model of the Early Stages of Barrett's Esophagus. Dunn LJ; Jankowski JA; Griffin SM Dig Dis Sci; 2015 May; 60(5):1187-94. PubMed ID: 25424203 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical assessment of Survivin and Bcl3 expression as potential biomarkers for NF-κB activation in the Barrett metaplasia-dysplasia-adenocarcinoma sequence. Puccio I; Khan S; Butt A; Graham D; Sehgal V; Patel D; Novelli M; Lovat LB; Rodriguez-Justo M; Hamoudi RA Int J Exp Pathol; 2018 Feb; 99(1):10-14. PubMed ID: 29473241 [TBL] [Abstract][Full Text] [Related]
13. Presence or absence of intestinal metaplasia but not its burden is associated with prevalent high-grade dysplasia and cancer in Barrett's esophagus. Bansal A; McGregor DH; Anand O; Singh M; Rao D; Cherian R; Wani SB; Rastogi A; Singh V; House J; Jones PG; Sharma P Dis Esophagus; 2014; 27(8):751-6. PubMed ID: 24165297 [TBL] [Abstract][Full Text] [Related]
14. Divergent expression of MUC5AC, MUC6, MUC2, CD10, and CDX-2 in dysplasia and intramucosal adenocarcinomas with intestinal and foveolar morphology: is this evidence of distinct gastric and intestinal pathways to carcinogenesis in Barrett Esophagus? Khor TS; Alfaro EE; Ooi EM; Li Y; Srivastava A; Fujita H; Park Y; Kumarasinghe MP; Lauwers GY Am J Surg Pathol; 2012 Mar; 36(3):331-42. PubMed ID: 22261707 [TBL] [Abstract][Full Text] [Related]
15. Barrett's esophagus: pathologic considerations and implications for treatment. Rice TW; Mendelin JE; Goldblum JR Semin Thorac Cardiovasc Surg; 2005; 17(4):292-300. PubMed ID: 16428035 [TBL] [Abstract][Full Text] [Related]
16. Volumetric laser endomicroscopy in the management of Barrett's esophagus. Trindade AJ; Leggett CL; Chang KJ Curr Opin Gastroenterol; 2017 Jul; 33(4):254-260. PubMed ID: 28402993 [TBL] [Abstract][Full Text] [Related]
17. Large intra- and inter-individual variability of genes expression levels limits potential predictive value of molecular diagnosis of dysplasia in Barrett's esophagus. Hennig EE; Mikula M; Orlowska J; Jarosz D; Bielasik A; Regula J; Ostrowski J J Mol Med (Berl); 2008 Feb; 86(2):233-42. PubMed ID: 17952395 [TBL] [Abstract][Full Text] [Related]
18. Identification and clinical implementation of biomarkers for Barrett's esophagus. Varghese S; Lao-Sirieix P; Fitzgerald RC Gastroenterology; 2012 Mar; 142(3):435-441.e2. PubMed ID: 22266150 [No Abstract] [Full Text] [Related]